- Home
- MNPR vs HBB Comparison
MNPR vs HBB Comparison
Compare MNPR & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- HBB
- Stock Information
- Founded
- MNPR 2014
- HBB 1904
- Country
- MNPR United States
- HBB United States
- Employees
- MNPR N/A
- HBB N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- HBB Home Furnishings
- Sector
- MNPR Health Care
- HBB Consumer Discretionary
- Exchange
- MNPR Nasdaq
- HBB Nasdaq
- Market Cap
- MNPR 248.8M
- HBB 242.8M
- IPO Year
- MNPR 2019
- HBB 2017
- Fundamental
- Price
- MNPR $44.21
- HBB $15.11
- Analyst Decision
- MNPR Strong Buy
- HBB
- Analyst Count
- MNPR 10
- HBB 0
- Target Price
- MNPR $66.56
- HBB N/A
- AVG Volume (30 Days)
- MNPR 38.8K
- HBB 33.0K
- Earning Date
- MNPR 11-07-2025
- HBB 10-29-2025
- Dividend Yield
- MNPR N/A
- HBB 3.18%
- EPS Growth
- MNPR N/A
- HBB N/A
- EPS
- MNPR N/A
- HBB 2.35
- Revenue
- MNPR N/A
- HBB $631,318,000.00
- Revenue This Year
- MNPR N/A
- HBB N/A
- Revenue Next Year
- MNPR N/A
- HBB N/A
- P/E Ratio
- MNPR N/A
- HBB $6.44
- Revenue Growth
- MNPR N/A
- HBB N/A
- 52 Week Low
- MNPR $2.29
- HBB $12.72
- 52 Week High
- MNPR $54.30
- HBB $31.78
- Technical
- Relative Strength Index (RSI)
- MNPR 65.29
- HBB 51.65
- Support Level
- MNPR $32.77
- HBB $14.24
- Resistance Level
- MNPR $36.49
- HBB $15.25
- Average True Range (ATR)
- MNPR 2.93
- HBB 0.73
- MACD
- MNPR 1.14
- HBB 0.24
- Stochastic Oscillator
- MNPR 99.97
- HBB 76.14
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.